Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors (original) (raw)

• Moe-Behrens GH, Pandolfi PP . Targeting aberrant transcriptional repression in acute myeloid leukaemia. Rev Clin Exp Hematol 2003; 7: 139–159.
  CAS PubMed Google Scholar
• Faretta M, Di Croce L, Pellici PG . Effects of the acute myeloid leukaemia-associated fusion proteins on nuclear architecture. Semin Haematol 2001; 38: 42–53.
  Article CAS Google Scholar
• Melnick A, Licht JD . Histone deactylases as therapeutic targets in hematologic malignancies. Curr Opin Hematol 2002; 9: 322–332.
  Article Google Scholar
• De Ruijter AJM, Van Gennip AH, Caron HN, Kemp S, Van Kuilenburg ABP . Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 2003; 370: 737–749.
  Article CAS Google Scholar
• Gregoretti IV, Lee Y-M, Goodson HV . Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J Mol Biol 2004; 338: 17–31.
  Article CAS Google Scholar
• Blander G, Guarente L . The Sir2 family of protein deacetylases. Annu Rev Biochem 2004; 73: 417–435.
  Article CAS Google Scholar
• Gao L, Cueto MA, Asselbergs F, Atadja P . Cloning and functional characterisation of HDAC11, a novel member of the human histone deacetylase family. J Biol Chem 2002; 277: 25748–25755.
  Article CAS Google Scholar
• Sengupta S, Seto E . Regulation of histone deacetylase activities. J Cell Biochem 2004; 93: 57–67.
  Article CAS Google Scholar
• Matsuyama A, Shimazu T, Sumida Y, Saito A, Yoshimatsu Y, Seigneurin-Berny D et al. In vivo destabilization of dynamic microtubules by HDAC6 mediated deacetylation. EMBO J 2002; 21: 6820–6831.
  Article CAS Google Scholar
• Langley E, Pearson M, Faretta M, Bauer UM, Frye RA, Minucci S et al. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J 2002; 21: 2383–2396.
  Article CAS Google Scholar
• Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A et al. Negative control of p53 by Sir2 promotes cell survival under stress. Cell 2001; 107: 137–148.
  Article CAS Google Scholar
• Vaziri H, Dessain SK, Ng EE, Imai SI, Frye RA, Pandita TK et al. _h_SIR2SIRT1 functions as an NAD-dependent p53 deacetylase. Cell 2002; 107: 149–159.
  Article Google Scholar
• Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004; 303: 2011–2105.
  Article CAS Google Scholar
• Motta MC, Divecha N, Lemieux M, Kamel C, Chen D, Gu W et al. Mammalian SIRT1 represses forkhead transcription factors. Cell 2004; 116: 551–563.
  Article CAS Google Scholar
• Marks PA, Richon VM, Miller T, Kelly WK . Histone deacetylase inhibitors. Adv Cancer Res 2004; 91: 137–168.
  Article CAS Google Scholar
• Kelly WK, O’Connor OA, Marks PA . Histone deacetylase inhibitors: from target to clinical trials. Expert Opin Investig Drugs 2002; 11: 1695–1713.
  Article CAS Google Scholar
• Barlow AL, van Drunen CM, Johnson CA, Tweedie S, Bird A, Turner BM . dSIR2 and dHDAC6: two novel, inhibitor resistant deacetylases in Drosophila melanogaster. Exp Cell Res 2001; 265: 90–103.
  Article CAS Google Scholar
• Gottlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 2001; 20: 6969–6978.
  Article CAS Google Scholar
• Turner BM, O’Neill LP, Allan IM . Histone H4 acetylation in human cells. Frequency of acetylation at different sites defined by immunolabeling with site specific antibodies. FEBS Lett 1989; 253: 141–145.
  Article CAS Google Scholar
• White DA, Belyaev ND, Turner BM . Preparation of site specific antibodies to acetylated histones. Methods 1999; 19: 417–424.
  Article CAS Google Scholar
• Johnson CA, White DA, Lavender JS, O’Neill LP, Turner BM . Human class I histone deacetylase complexes show enhanced catalytic activity in the presence of ATP and co-immunoprecipitate with the ATP-dependent chaperone protein Hsp70. J Biol Chem 2002; 277: 9590–9597.
  Article CAS Google Scholar
• Drexler HG, Quentmeier H, MacLeod RAF, Uphoff CC, Hu Z-B . Leukemia cell lines: in vitro models for the study of acute promyelocytic leukaemia. Leukemia Res 1995; 19: 681–691.
  Article CAS Google Scholar
• Kramer OH, Zhu P, Ostendorff HP, Golebiewski M, Tiefenbach J, Peters MA et al. The histone decetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J 2003; 22: 3411–3420.
  Article Google Scholar
• Whitlock JP, Galeazzi D, Schulman H . Acetylation and calcium-dependent phosphorylation of histone H3 in nuclei from butyrate-treated HeLa cells. J Biol Chem 1983; 258: 1299–1304.
  CAS PubMed Google Scholar
• Osada H, Tatematsu Y, Saito H, Yatabe Y, Mitsudomi T, Takahashi T . Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients. Int J Cancer 2004; 112: 26–32.
  Article CAS Google Scholar
• Zhu P, Martin E, Mengwasser J, Schlag P, Janssen K-P, Gottlicher M . Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell 2004; 5: 455–463.
  Article CAS Google Scholar
• Araki T, Sasaki Y, Milbrandt J . Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 2004; 305: 1010–1013.
  Article CAS Google Scholar
• Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, Patel P et al. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci USA 2003; 100: 10794–10799.
  Article CAS Google Scholar
• Fulco M, Schlitz RL, Iezzi S, King MT, Zhao P, Kishiwaya Y et al. Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol Cell 2003; 12: 51–62.
  Article CAS Google Scholar
• Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004; 305: 390–396.
  Article CAS Google Scholar
• Lachner M, O’Sullivan RJ, Jenuwein TJ . An epigenetic road map for histone lysine methylation. J Cell Sci 2003; 116: 2117–2124.
  Article CAS Google Scholar
• Milne TA, Briggs SD, Brock HW, Martin ME, Gibbs D, Allis CD et al. MLL targets SET domain methyltransferase activity to HOX gene promoters. Mol Cell 2002; 10: 1107–1117.
  Article CAS Google Scholar
• Van Lint C, Emiliani S, Verdin E . The expression of a small fraction of cellular gene is changed in response to histone hyperacetylation. Gene Exp 1996; 5: 245–254.
  CAS Google Scholar
• Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, Weijenberg MP et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002; 31: 141–149.
  Article CAS Google Scholar
• Peart MJ, Smyth GK, van Laar RK, Bowtell DD, Richon VM, Marks PA et al. Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors. Proc Natl Acad Sci USA 2005; 102: 3697–3702.
  Article CAS Google Scholar
• Kyrylenko S, Kyrylenko O, Suuronen T, Salminen A . Differential regulation of the Sir2 histone deacetylase genes by inhibitors of class I and II histone deacetylases. Cell Mol Life Sci 2003; 60: 1990–1997.
  Article CAS Google Scholar